Evidence map›Paper›PMID 41376731›Full record

ArticleCureus2025

Severe Hypernatremia During Continuous Hemofiltration in an End-Stage Renal Disease (ESRD) Patient From the Kingdom of Saudi Arabia: A Case Report and Updated Review.

Fahad S Alrashidi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fahad S AlrashidiInternal Medicine/Nephrology, Ad Diriyah Hospital, Riyadh Third Health Cluster, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a 74-year-old female with end-stage renal disease (ESRD) on maintenance hemodialysis who was admitted with community-acquired pneumonia and decreased level of consciousness. She required intubation and was transferred to the intensive care unit, where continuous renal replacement therapy (CRRT) was initiated. Her initial serum sodium was markedly elevated at 154 mmol/L. Careful adjustment of dialysate and replacement fluid sodium concentrations allowed gradual correction, avoiding cerebral edema or osmotic demyelination. This case highlights the importance of individualized CRRT prescription and close biochemical monitoring to achieve safe sodium correction in critically ill patients.

Indexed as

clinical nephrologycontinuous renal replacement therapy (crrt)internal medicinemedical intensive care uniton dialysissodium disorder

Identifiers

PMID41376731
PMCPMC12686975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.